Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 9814038, 6 pages
http://dx.doi.org/10.1155/2016/9814038
Research Article

The Regulatory Role of Nuclear Factor Kappa B in the Heart of Hereditary Hypertriglyceridemic Rat

1Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilization Diseases, Slovak Academy of Sciences, 813 71 Bratislava, Slovakia
2Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, Czech Republic
3Centre of Cardiovascular Research, 142 20 Prague 4, Czech Republic

Received 25 December 2015; Accepted 28 March 2016

Academic Editor: Sergio Di Meo

Copyright © 2016 Stanislava Vranková et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Liu, R. Colavitti, I. I. Rovira, and T. Finkel, “Redox-dependent transcriptional regulation,” Circulation Research, vol. 97, no. 10, pp. 967–974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Bar-Shai, E. Carmeli, P. Ljubuncic, and A. Z. Reznick, “Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-κB activation,” Free Radical Biology and Medicine, vol. 44, no. 2, pp. 202–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-H. Kwak, J.-K. Jung, and H. Lee, “Nuclear factor-kappa B inhibitors; a patent review (2006–2010),” Expert Opinion on Therapeutic Patents, vol. 21, no. 12, pp. 1897–1910, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. I. M. Grumbach, W. Chen, S. A. Mertens, and D. G. Harrison, “A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 4, pp. 595–603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Morgan and Z.-G. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, no. 1, pp. 103–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tranter, X. Ren, T. Forde et al., “NF-ΚB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning,” Journal of Molecular and Cellular Cardiology, vol. 49, no. 4, pp. 664–672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Napetschnig and H. Wu, “Molecular basis of NF-κB signaling,” Annual Review of Biophysics, vol. 42, no. 1, pp. 443–468, 2013. View at Publisher · View at Google Scholar
  8. C. K. Sen, S. Khanna, A. Z. Reznick, S. Roy, and L. Packer, “Glutathione regulation of tumor necrosis factor-α-induced NF-κB activation in skeletal muscle-derived L6 cells,” Biochemical and Biophysical Research Communications, vol. 237, no. 3, pp. 645–649, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Chen, V. Castranova, Z. Li, M. Karin, and X. Shi, “Inhibitor of nuclear factor kappa B kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic,” Cancer Research, vol. 63, pp. 7689–7693, 2003. View at Google Scholar
  10. A. Vrána and L. Kazdová, “The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia,” Transplantation Proceedings, vol. 22, no. 6, p. 2579, 1990. View at Google Scholar · View at Scopus
  11. J. Zicha, O. Pecháňová, S. Čačányiová et al., “Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome?” Physiological Research, vol. 55, supplement 1, pp. S49–S63, 2006. View at Google Scholar · View at Scopus
  12. L. Kazdová, A. Žák, and A. Vrána, “Increased lipoprotein oxidability and aortic lipid peroxidation in an experimental model of insulin resistance syndrome,” Annals of the New York Academy of Sciences, vol. 827, pp. 521–525, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-M. Shin, M.-H. Kim, B. H. Kim et al., “Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-κB without affecting IκB degradation,” FEBS Letters, vol. 571, no. 1–3, pp. 50–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Kogure, B. D. Watson, R. Busto, and K. Abe, “Potentiation of lipid peroxides by ischemia in rat brain,” Neurochemical Research, vol. 7, no. 4, pp. 437–454, 1982. View at Publisher · View at Google Scholar · View at Scopus
  15. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Publisher · View at Google Scholar
  16. D. S. Bredt and S. H. Snyder, “Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 2, pp. 682–685, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Pecháňová, I. Bernátová, V. Pelouch, and F. Šimko, “Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril,” Journal of Molecular and Cellular Cardiology, vol. 29, no. 12, pp. 3365–3374, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Pecháňová, J. Zicha, S. Kojšová, Z. Dobešová, L. Jendeková, and J. Kuneš, “Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension,” Clinical Science, vol. 110, no. 2, pp. 235–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Simko, I. Luptak, J. Matuskova et al., “Heart remodeling in the hereditary hypertriglyceridemic rat: Effect of captopril and nitric oxide deficiency,” Annals of the New York Academy of Sciences, vol. 967, pp. 454–462, 2002. View at Google Scholar · View at Scopus
  20. J. Kuneš, Z. Dobešová, and J. Zicha, “Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia,” Clinical Science, vol. 102, no. 3, pp. 269–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Žourek, P. Kyselová, J. Mudra et al., “The relationship between glycemia, insulin and oxidative stress in hereditary hypertriglyceridemic rat,” Physiological Research, vol. 57, no. 4, pp. 531–538, 2008. View at Google Scholar · View at Scopus
  22. N. Škottová, L. Kazdová, O. Oliyarnyk, R. Večeřa, L. Sobolová, and J. Ulrichová, “Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats,” Pharmacological Research, vol. 50, no. 2, pp. 123–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Vranková, J. Parohová, A. Barta, P. Janega, F. Šimko, and O. Pecháňová, “Effect of nuclear factor kappa B inhibition on L-NAME-induced hypertension and cardiovascular remodelling,” Journal of Hypertension, vol. 28, no. 1, pp. S45–S49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. H. Lee, D.-H. Hyun, P. Jenner, and B. Halliwell, “Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production,” Journal of Neurochemistry, vol. 78, no. 1, pp. 32–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. N. C. Ward and K. D. Croft, “Hypertension and oxidative stress,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 9, pp. 872–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Kojšová, L. Jendeková, J. Zicha, J. Kuneš, R. Andriantsitohaina, and O. Pecháňová, “The effect of different antioxidants on nitric oxide production in hypertensive rats,” Physiological Research, vol. 55, supplement 1, pp. S3–S16, 2006. View at Google Scholar · View at Scopus
  27. C. S. Wilcox and A. Pearlman, “Chemistry and antihypertensive effects of tempol and other nitroxides,” Pharmacological Reviews, vol. 60, no. 4, pp. 418–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Skibska and A. Goraca, “The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 313021, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. P. X. Shaw, G. Werstuck, and Y. Chen, “Oxidative stress and aging diseases,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 569146, 2 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Woodward, K. D. Croft, T. A. Mori et al., “Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population,” Clinical Science, vol. 116, no. 1, pp. 53–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Dröge, K. Schulze-Osthoff, S. Mihm et al., “Functions of glutathione and glutathione disulfide in immunology and immunopathology,” The FASEB Journal, vol. 8, no. 14, pp. 1131–1138, 1994. View at Google Scholar · View at Scopus
  33. M.-L. Cho, Y.-M. Moon, Y.-J. Heo et al., “NF-κB inhibition leads to increased synthesis and secretion of MIF in human CD4+ T cells,” Immunology Letters, vol. 123, no. 1, pp. 21–30, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Sasazuki, T. Okazaki, K. Tada et al., “Genome wide analysis of TNF-inducible genes reveals that antioxidant enzymes are induced by TNF and responsible for elimination of ROS,” Molecular Immunology, vol. 41, no. 5, pp. 547–551, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. D. M. Townsend, K. D. Tew, and H. Tapiero, “The importance of glutathione in human disease,” Biomedicine and Pharmacotherapy, vol. 57, no. 3, pp. 145–155, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. M. C. Santos-Silva, M. S. D. Freitas, and J. Assreuy, “Involvement of NF-κB and glutathione in cytotoxic effects of nitric oxide and taxol on human leukemia cells,” Leukemia Research, vol. 30, no. 2, pp. 145–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Zhang, C.-N. Ong, and H.-M. Shen, “Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells,” Cancer Letters, vol. 208, no. 2, pp. 143–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. G. Orr, V. Leel, G. A. Cameron et al., “Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells,” Hepatology, vol. 40, no. 1, pp. 232–242, 2004. View at Publisher · View at Google Scholar · View at Scopus